Divergent Trends of Anti-JCPyV Serum Reactivity and Neutralizing Activity in Multiple Sclerosis (MS) Patients during Treatment with Natalizumab

The association between natalizumab and progressive multifocal leukoencephalopathy (PML) is established, but a reliable clinical risk stratification flow-chart is lacking. New risk factors are needed, such as the possible role of the anti-JC polyomavirus (JCPyV) neutralizing antibody. In this pilot...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Viruses
Main Authors: Diotti, Roberta Antonia, Capra, Ruggero, Moiola, Lucia, Caputo, Valeria, De Rossi, Nicola, Sangalli, Francesca, Martinelli, Vittorio, Burioni, Roberto, Clementi, Massimo, Mancini, Nicasio
Formato: Artigo
Idioma:Inglês
Publicado em: MDPI 2016
Assuntos:
Communication
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4885083/
https://ncbi.nlm.nih.gov/pubmed/27164128
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/v8050128
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados